ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,584.54
      -0.88%
      US Tech 100
      19,666.40
      -2.25%
      Dow Jones
      39,753.75
      0.08%
      Brent Oil
      85.06
      0.01%
      Bitcoin
      57,385.83
      -0.64%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Neoleukin Therapeutics Inc (NLTX)

      7. Neoleukin Therapeutics Inc (NLTX) News

      NLTX

      Neoleukin Therapeutics (NLTX)

      Neoleukin Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:NLTX
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      09/10/20208:17AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NLTXNeoleukin Therapeutics Inc
      09/10/20208:00AMGlobeNewswire Inc.Neoleukin Therapeutics Announces Appointment of Martin Babler to Board of DirectorsNASDAQ:NLTXNeoleukin Therapeutics Inc
      09/09/20208:00AMGlobeNewswire Inc.Neoleukin Therapeutics to Present at H.C. Wainwright 22nd Annual Global Investment ConferenceNASDAQ:NLTXNeoleukin Therapeutics Inc
      08/12/20204:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NLTXNeoleukin Therapeutics Inc
      08/12/20204:06PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NLTXNeoleukin Therapeutics Inc
      08/12/20204:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NLTXNeoleukin Therapeutics Inc
      08/12/20204:01PMGlobeNewswire Inc.Neoleukin Therapeutics Announces Second Quarter 2020 Financial Results & Provides Corporate UpdateNASDAQ:NLTXNeoleukin Therapeutics Inc
      08/06/20208:00AMGlobeNewswire Inc.Neoleukin Therapeutics to Present at Canaccord Genuity 40th Annual Growth ConferenceNASDAQ:NLTXNeoleukin Therapeutics Inc
      08/05/20208:00AMGlobeNewswire Inc.Neoleukin Therapeutics to Host Second Quarter 2020 Financial Results & Corporate Update Conference Call and Webcast on August...NASDAQ:NLTXNeoleukin Therapeutics Inc
      07/02/20204:37PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NLTXNeoleukin Therapeutics Inc
      07/02/20204:26PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NLTXNeoleukin Therapeutics Inc
      07/02/20209:00AMGlobeNewswire Inc.Neoleukin Therapeutics Announces Pricing of $76.2 Million Public OfferingNASDAQ:NLTXNeoleukin Therapeutics Inc
      07/01/20204:13PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NLTXNeoleukin Therapeutics Inc
      07/01/20204:01PMGlobeNewswire Inc.Neoleukin Therapeutics Announces Proposed Public OfferingNASDAQ:NLTXNeoleukin Therapeutics Inc
      06/22/20209:05AMGlobeNewswire Inc.Neoleukin Therapeutics Presents Preclinical Data for NL-201 and De Novo Protein Design Technology at American Association for...NASDAQ:NLTXNeoleukin Therapeutics Inc
      06/15/20208:00AMGlobeNewswire Inc.Neoleukin Therapeutics to Host Investor R&D Showcase Highlighting De Novo Protein TherapeuticsNASDAQ:NLTXNeoleukin Therapeutics Inc
      06/02/20204:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NLTXNeoleukin Therapeutics Inc
      06/02/20204:30PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NLTXNeoleukin Therapeutics Inc
      06/01/20208:32AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NLTXNeoleukin Therapeutics Inc
      06/01/20208:00AMGlobeNewswire Inc.Neoleukin Therapeutics Announces Appointment of Erin Lavelle to Board of DirectorsNASDAQ:NLTXNeoleukin Therapeutics Inc
      05/27/20208:00AMGlobeNewswire Inc.Neoleukin Therapeutics to Present at Jefferies Virtual Healthcare ConferenceNASDAQ:NLTXNeoleukin Therapeutics Inc
      05/15/20207:00AMGlobeNewswire Inc.Neoleukin Therapeutics Announces Multiple Presentations at American Association for Cancer Research (AACR) Virtual Annual Mee...NASDAQ:NLTXNeoleukin Therapeutics Inc
      05/07/20205:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NLTXNeoleukin Therapeutics Inc
      05/07/20204:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NLTXNeoleukin Therapeutics Inc
      05/07/20204:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NLTXNeoleukin Therapeutics Inc
      05/07/20204:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NLTXNeoleukin Therapeutics Inc
      05/07/20204:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NLTXNeoleukin Therapeutics Inc
      05/07/20208:00AMGlobeNewswire Inc.Neoleukin Therapeutics to Present at Virtual BofA Securities 2020 Health Care ConferenceNASDAQ:NLTXNeoleukin Therapeutics Inc
      05/06/20204:09PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NLTXNeoleukin Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:NLTX